Skip to content

CohortPlat

Simulation of Cohort Platform Trials for Combination Treatments

v1.0.5 · Feb 14, 2022 · MIT + file LICENSE

Description

A collection of functions dedicated to simulating staggered entry platform trials whereby the treatment under investigation is a combination of two active compounds. In order to obtain approval for this combination therapy, superiority of the combination over the two active compounds and superiority of the two active compounds over placebo need to be demonstrated. A more detailed description of the design can be found in Meyer et al. <DOI:10.1002/pst.2194> and a manual in Meyer et al. <arXiv:2202.02182>.

Downloads

303

Last 30 days

13257th

908

Last 90 days

3.5K

Last year

Trend: +18.4% (30d vs prior 30d)

CRAN Check Status

2 NOTE
11 OK
Show all 13 flavors
Flavor Status
r-devel-linux-x86_64-debian-clang NOTE
r-devel-linux-x86_64-debian-gcc NOTE
r-devel-linux-x86_64-fedora-clang OK
r-devel-linux-x86_64-fedora-gcc OK
r-devel-windows-x86_64 OK
r-oldrel-macos-arm64 OK
r-oldrel-macos-x86_64 OK
r-oldrel-windows-x86_64 OK
r-patched-linux-x86_64 OK
r-release-linux-x86_64 OK
r-release-macos-arm64 OK
r-release-macos-x86_64 OK
r-release-windows-x86_64 OK
Check details (2 non-OK)
NOTE r-devel-linux-x86_64-debian-clang

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
NOTE r-devel-linux-x86_64-debian-gcc

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.

Check History

NOTE 11 OK · 2 NOTE · 0 WARNING · 0 ERROR · 0 FAILURE Jun 9, 2026
NOTE r-devel-linux-x86_64-debian-clang

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
NOTE r-devel-linux-x86_64-debian-gcc

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
ERROR 11 OK · 1 NOTE · 0 WARNING · 1 ERROR · 0 FAILURE Jun 8, 2026
NOTE r-devel-linux-x86_64-debian-clang

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
ERROR r-devel-linux-x86_64-debian-gcc

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
NOTE 12 OK · 2 NOTE · 0 WARNING · 0 ERROR · 0 FAILURE Mar 10, 2026
NOTE r-devel-linux-x86_64-debian-clang

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.
NOTE r-devel-linux-x86_64-debian-gcc

CRAN incoming feasibility

Maintainer: ‘Elias Laurin Meyer <elias.meyer@meduniwien.ac.at>’

The Description field contains
  in Meyer et al. <arXiv:2202.02182>.
Please refer to arXiv e-prints via their arXiv DOI <doi:10.48550/arXiv.YYMM.NNNNN>.

Dependency Network

Dependencies Reverse dependencies dplyr purrr ggplot2 plotly tidyr doParallel foreach openxlsx forcats epitools zoo CohortPlat

Version History

6 tracked
new 1.0.5 Mar 10, 2026
updated 1.0.5 ← 1.0.4 diff Feb 13, 2022
updated 1.0.4 ← 1.0.3 diff Feb 8, 2022
updated 1.0.3 ← 1.0.1 diff May 16, 2021
updated 1.0.1 ← 1.0.0 diff May 9, 2021
new 1.0.0 Jan 24, 2021